Evidence map›Paper›PMID 11679032›Full record

ArticleJournal of general internal medicine2001

Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network.

M McNaughton Collins, M A Pontari, M P O'Leary, E A Calhoun, J Santanna, J R Landis, J W Kusek, M S Litwin, Chronic Prostatitis Collaborative Research Network

Registry-linked trialOpen access · bronzeAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of general internal medicine, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05306314 (A Study to Understand the Treatment Patterns in Patients With Chronic Bacterial Prostatitis), which is not on this map. Cited by 104 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 6 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05306314 unknown statusnot on this mapstarted 2022, after this paper: background citation

A Study to Understand the Treatment Patterns in Patients With Chronic Bacterial Prostatitis (Category II), Chronic Pelvic Pain (Category IIIA, IIIB)Treataprost Added to Standard Antibiotic Treatment in Real-life Clinical Practice

TypeobservationalSponsorGMG Grand MedicalRan2022 to 2023Enrolled140ConditionsQuality of Life, Infection, Bacterial, PSA, ProstatitisArmsTREATAPROST
3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 6 syntheses or guidelines pooled it, 286 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI).Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2006
    Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. [Chronic prostatitis/chronic pelvic pain syndrome].Urologie (Heidelberg, Germany) · 2023
    Review
  20. Case report: Successful treatment of recurrentFrontiers in pharmacology · 2023
    Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

M McNaughton CollinsGeneral Medicine Unit, Medical Services, Massachusetts General Hospital, Boston, MA 02114, USA. mmcnaughtoncollins@partners.org
M A Pontari
M P O'Leary
E A Calhoun
J Santanna
J R Landis
J W Kusek
M S Litwin
Chronic Prostatitis Collaborative Research Network
University of Pennsylvania · USBrigham and Women's Hospital · USMassachusetts General Hospital · USNational Institute of Diabetes and Digestive and Kidney Diseases · USNorthwestern University · USTemple University · USUniversity of California, Los Angeles · US

Funding

BIOSTATISTICS SUPPORT CENTER FOR CHRONIC PROSTATITISU01DK053752 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LANDIS, J RICHARD · 2000 to 2002
$3.2M
Amygdala kappa opioid system involvement in opioid relapse in pain statesR01DA053752 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CATHERINE M CAHILL · 2022 to 2026
$2.8M
Mechanisms and treatment of adolescent phytocannabinoid impairment of prefrontal cortex functionR01DA053746 · NIDA · TRUSTEES OF INDIANA UNIVERSITY · PI HUI-CHEN LU, Kenneth Mackie · 2022 to 2026
$2.2M
BIOSTATISTICS SUPPORT CENTER FOR CHRONIC PROSTATITISR01DK053752 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LANDIS, J RICHARD · 1997 to 2000
$200k
CHRONIC PROSTATITIS COLLABORATIVE CLINICAL STUDIESR01DK053732 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI ALEXANDER, RICHARD B · 1997 to 1999
–
CHRONIC PROSTATITIS CLINICAL RESEARCH CENTERR01DK053734 · NIDDK · TEMPLE UNIVERSITY · PI PONTARI, MICHEL · 1997 to 1999
–
CHRONIC PROSTATITIS COLLABORATIVE CLINICAL STUDIESR01DK053736 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI O'LEARY, MICHAEL P · 1997 to 1999
–
CHARACTERIZATION &TREATMENT OF CATEGORY III PROSTATITISR01DK053746 · NIDDK · QUEEN'S UNIVERSITY AT KINGSTON · PI NICKEL, J CURTIS · 1998 to 1999
–
CHRONIC PROSTATITIS COLLABORATIVE CLINICAL RESEARCHR01DK053730 · NIDDK · NORTHWESTERN UNIVERSITY · PI SCHAEFFER, ANTHONY J · 1997 to 1999
–
NIDA NIH HHS R01 DA053746NIDA NIH HHS R01 DA053752NIDDK NIH HHS R01 DK053732NIDDK NIH HHS R01 DK53730NIDDK NIH HHS R01 DK53732NIDDK NIH HHS R01 DK53734NIDDK NIH HHS R01 DK53736NIDDK NIH HHS R01 DK53746NIDDK NIH HHS R01 DK53752
6 · The paper itself

Abstract

objectiveHealth-related quality of life (HRQOL) impairment may be a central component of chronic prostatitis for men afflicted with this condition. Our objective was to examine HRQOL, and factors associated with HRQOL, using both general and condition-specific instruments.

designChronic Prostatitis Cohort (CPC) study.

settingSix clinical research centers across the United States and Canada.

participantsTwo hundred seventy-eight men with chronic prostatitis. MEASUREMENTS AND MAIN

resultsThe Short Form 12 (SF-12) Mental Component Summary (MCS) and Physical Component Summary (PCS), and the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) were measures used. CPC subjects' MCS scores (44.0 +/- 9.8) were lower than those observed in the most severe subgroups of patients with congestive heart failure and diabetes mellitus, and PCS scores (46.4+/-9.5) were worse than those among the general U.S. male population. Decreasing scores were seen in both domains with worsening symptom severity (P < .01). History of psychiatric disease and younger age were strongly associated with worse MCS scores, whereas history of rheumatologic disease was associated with worse PCS scores. Predictors of more severe NIH-CPSI scores included lower educational level and lower income; history of rheumatic disease was associated with higher scores.

conclusionsMen with chronic prostatitis experience impairment in the mental and physical domains of general HRQOL, as well as condition-specific HRQOL. To optimize the care of men with this condition, clinicians should consider administering HRQOL instruments to their patients to better understand the impact of the condition on patients' lives.

Indexed as

ProstatitisQuality of LifeAdultChronic DiseaseHealth Status IndicatorsHumansMaleMiddle AgedProspective Studies

Identifiers

PMID11679032
PMCPMC1495276
OpenAlexW2026467462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.